Walgreens to offer Auvi-Q as EpiPen shortage challenges parents
Walgreens will inventory the Auvi-Q as an EpiPen scarcity has left some pharmacies unable to fill prescriptions of the lifesaving allergy remedy, leaving some dad and mom scrambling.
Like EpiPen, the Auvi-Q delivers epinephrine to deal with extreme allergic reactions. The small rectangular auto-injector walks folks by its use. Drugmaker Kaleo’s partnership with Walgreens would be the first time the Auvi-Q has been obtainable at retail pharmacies. At the moment, sufferers can solely obtain the gadgets by the mail.
The Auvi-Q’s introduction to Walgreens comes as manufacturing disruptions have led to an EpiPen scarcity. Drugstores throughout the nation haven’t any or only a few EpiPens in inventory. It is particularly irritating for folks who’re attempting to replenish and ship their youngsters again to highschool with a contemporary provide of remedy.
One doable disadvantage is the Auvi-Q’s price ticket: $four,500 for 2 auto-injectors. Kaleo, a privately held firm, mentioned eligible sufferers with business insurance coverage, even these with excessive deductible plans, can acquire the Auvi-Q for free of charge. Not each insurer covers it. Nevertheless, not each insurer covers it.
For sufferers whose insurers do not cowl the Auvi-Q, Kaleo will present it to them at no cost. Folks with out insurance coverage can apply for an help program.
“We’re working with insurance coverage suppliers to maximise protection of AUVI-Q for as many sufferers as doable,” Phil Rackliffe, basic supervisor of Allergy and Pediatrics at Kaleo, mentioned in an announcement.
Mylan markets EpiPen, whereas Pfizer producers it. Provide points began in Could, however the college 12 months has added extra stress to the scenario. Amneal Prescribed drugs, which makes the Adrenaclick, has additionally confronted manufacturing points this 12 months. Pfizer additionally produces that drug.
The Meals and Drug Administration accepted a generic model of EpiPen final month. Its producer, Teva, mentioned it will launch the drug “within the coming months” however did not specify a date when saying its approval.
Sufferers who cannot fill their epinephrine prescriptions can work with Walgreens pharmacists and their physician to see if the Auvi-Q is suitable for them.
“Walgreens pharmacists proceed to take care of and work with sufferers and their prescribers to make sure they’ve entry to the epinephrine auto-injectors they want, and we’re happy to work with kaléo to assist meet the demand for epinephrine auto-injectors throughout the nation,” Walgreens President of Operations Richard Ashworth mentioned in an announcement.
contributed to this report
Supply hyperlink – https://www.cnbc.com/2018/09/06/walgreens-to-offer-auvi-q-as-epipen-shortage-challenges-parents.html